DG Science et Thérapies SRL
DG Science et Thérapies reported total assets of 81,097 € at the end of the 2025 financial year (annual accounts filed with the NBB on 27 Aug 2026).
The score of DG Science et Thérapies shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
The full file covers 2 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
DG Science et Thérapies's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 27 Aug 2026
- Year ended 31 Dec 2024filed on 16 Jul 2025
DG Science et Thérapies's financial analysis
- Solvency35.5%sector median: 61.1%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of DG Science et Thérapies
DG Science et Thérapies's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1017.196.834
- VAT number
- BE1017196834
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- SRL
- Incorporated
- 11 Dec 2024
- Registered office
- 1090 Jette
- Latest accounts
- 2025 · filed on 27 Aug 2026
- Activity
- Physical therapy activities (NACE 86951)
DG Science et Thérapies (SRL) has been based in Jette since 2024, active in: physical therapy activities. For 2025, it reports a net profit of 9,394 € and equity of 28,788 €; its revenue is not published. Its solvency stands at 35.5%, below the median of its sector (61.1%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to DG Science et Thérapies
Companies in the same business, of comparable size and area, outside its group.
- La Gazette D' Abidjan Market research and public opinion polling Ixelles · balance sheet 81,020 €
- Chatrium Manufacture of basic pharmaceutical products Turnhout · balance sheet 81,018 €
- Kinesitherapeute Tien le Sports and recreation education Kalmthout · balance sheet 81,176 €
- Sysplasma Manufacture of electronic components Ghent · balance sheet 81,197 €
Frequently asked questions about DG Science et Thérapies
What is the revenue of DG Science et Thérapies?
DG Science et Thérapies files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of DG Science et Thérapies?
In Belgium, the VAT number is the company number prefixed with BE: BE1017196834 for DG Science et Thérapies, if the company is VAT-registered. Its company number (CBE) is 1017.196.834.
Where is the registered office of DG Science et Thérapies?
According to the CBE register, the registered office of DG Science et Thérapies is in 1090 Jette.
What is the equity of DG Science et Thérapies?
At the close of the 2025 financial year, the equity of DG Science et Thérapies amounts to 28,788 €, a solvency of 35.5% of total assets.
Who manages DG Science et Thérapies?
The register lists 1 active mandates at DG Science et Thérapies. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of DG Science et Thérapies
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →